Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 19Other hematologic neoplasm 16Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Large Granular Lymphocytic 1Hodgkin Disease 1

Interventions

fludarabine 13Specimen Handling 13Cyclophosphamide 13Biopsy 12fludarabine phosphate 11Whole-Body Irradiation 9Cytarabine 9venetoclax 8X-Rays 8Magnetic Resonance Spectroscopy 8asciminib 7Injections 7Azacitidine 7Nuclear Medicine Department, Hospital 6Mycophenolic Acid 6CPX-351 6Busulfan 6ruxolitinib 5ivosidenib 5decitabine and cedazuridine drug combination 5Tacrolimus 5Phantoms, Imaging 5Peripheral Blood Stem Cell Transplantation 5Melphalan 5Cyclosporine 5nilotinib 4Imatinib Mesylate 4Granulocyte Colony-Stimulating Factor 4Filgrastim 4Dasatinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
blinatumomab × Myeloid × 30 days × Clear all
NCT03849651 2026-06-03

TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
69 enrolled 17 charts
LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡